When endoscopic therapy is used for the treatment of patients with painful chronic pancreatitis, extracorporeal shock wave lithotripsy (ESWL) can be proposed as a first-line approach when obstructive ductal stone(s) induce upstream dilation of the main pancreatic duct. Stone fragmentation by ESWL is followed by endoscopic ductal drainage using pancreatic sphincterotomy, fragmented stone(s) extraction, and pancreatic stenting in case of ductal stricture. After completion of endoscopic pancreatic ductal drainage, long-term clinical benefit can be expected for two thirds of the patients. Best clinical results are associated with absence or cessation of smoking and with early treatment in the course of chronic pancreatitis, while alcohol abuse increases the risks of diabetes, steatorrhea and mortality.
INTRODUCTION
Chronic pancreatitis is a progressive inflammatory disease of the pancreas characterized by destruction of pancreatic parenchyma with subsequent fibrosis (1).
The natural course of chronic pancreatitis is often complicated by the occurrence of stones within the main pancreatic duct, followed by ductal obstruction, an increase in intraductal as well as parenchymal pressure, and ischemia. These factors are thought to be (partly) responsible for pancreatic pain (2).
Currently, in patients with painful chronic pancreatitis and a dilated pancreatic duct, endoscopic treatment consisting of drainage of the main pancreatic duct, extraction of stones or drainage of a pseudocyst has been increasingly used with clinical results that are comparable with those of conventional surgery (3).
The objectives of the endoscopic treatment are to alleviate pain by decompressing the main pancreatic duct and obtaining good ductal drainage, by draining pancreatic pseudocysts and by improving common bile duct strictures which have resulted from chronic pancreatitis.
PANCREATIC DUCT DRAINAGE
Therapeutic endoscopy offers several modalities for pancreatic duct drainage including endoscopic pancreatic sphincterotomy (4), stone removal (5), extracorporeal shock wave lithotripsy (ESWL) for pancreatic stones unextractable by endoscopic techniques alone (6), and insertion of pancreatic stent(s) for stricture of the distal main pancreatic duct (7) . METHODS In addition to standard laboratory tests and routine plain films of the pancreatic area for detection of pancreatic calcifications, magnetic resonance imaging (MRI) is currently the non-invasive modality of choice that allows the selection of patients who might benefit from endoscopic treatment (8). Indeed, with MR technology, the pancreatic ductal anatomy (by magnetic resonance cholangiopancreatography with secretin stimulation) and peripancreatic fluid collections are seen (Fig. 1) , and the parenchyma can also be assessed with or without contrast medium. Therefore, patients with chronic pancreatitis and pain selected for endotherapy are those with obstruction of the main pancreatic duct by strictures and/or stones, those with fluid collections resulting from downstream ductal obstruction or disruption of a pancreatic duct and those with obstruction of the common bile duct caused either by fibrotic changes in the pancreas or by compression by a pancreatic pseudocyst (9).
Methods for the main pancreatic duct drainage procedures are described in detail elsewhere (9).
Briefly, biliary sphincterotomy is performed before endoscopic pancreatic sphincterotomy in cases of cholangitis or obstructive jaundice, when there is cholestasis, or when it is technically necessary to separate the two orifices to facilitate access to the pancreatic duct. Endoscopic pancreatic sphincterotomy is performed after deep cannulation of the main pancreatic duct by means of a guide-wire, before or after ESWL when appropriate. Section of the pancreatic sphincter is performed under direct vision with a standard pull-type sphincterotome using only pure cutting current and is extended to the duodenal wall. The same technique is used for minor papilla sphincterotomy.
In case of pancreatic stones unextractable from the main pancreatic duct, ESWL is performed, preferably with a lithotripter including a bidimensional Xray focusing system.
After extraction of the stone fragments with a Dormia basket or a balloon catheter, a nasopancreatic catheter is inserted for further lavage or drainage of the main pancreatic duct.
Insertion of one or multiple pancreatic stent(s) is indicated in patients with a dominant stricture of the distal main pancreatic duct. TECHNICAL 
RESULTS
In a multicenter study of more than 1000 patients with painful chronic pancreatitis, pancreatic ductal obstruction was due to the presence of intraductal obstructive stones alone in 18 % of the cases, due to stricture(s) of the main pancreatic duct in 47 % of the cases, and due to both stone(s) and stricture(s) in 32 % of the cases (10) .
Small calculi within the main pancreatic duct can be extracted endoscopically (5). For large or impacted stones, or in case of main pancreatic duct stenosis, endoscopic removal is usually impossible. In these patients, ESWL, regardless of the method of A B Fig. 1 .A 61-year-old man with chronic alcoholic pancreatitis presented with continuous epigastric pain and weight loss. There was no diabetes and no steatorrhea. AM agnetic resonance cholangiopancreatography (MRCP) showed upstream dilation of the main pancreatic duct (MPD) above a distal ductal obstruction. BA fter stone fragmentation and pancreatic duct stenting (see shock waves generation (electrohydraulic, electromagnetic or piezoelectric), has proved efficient for disintegrating stones into small fragments ( Fig. 2A -B) before clearance of the duct can be achieved. Numerous reports describe ESWL as a low-risk, technically successful method with fragmentation rates of up to 100 % (6, [11] [12] [13] [14] . Nevertheless complete clearance of the main pancreatic duct can only be achieved in 40 % to 75 % of patients (6, 11-13, 15, 16 ). However, technical success of endoscopic ductal drainage is generally defined as a decrease in main pancreatic duct diameter with or without complete ductal stone clearance (17) . It was obtained in 54 % to 99 % of the cases in the largest published series (6, 10-13, 17-20) (Table 1) .
Dumonceau et al (11) identified ESWL as the only independent factor associated to technical success. In most reports, successful fragmentation and stone clearance have not correlated with the initial size or the number of main pancreatic duct stones (6, 10, 12, 13, 17) , except in one series involving 80 patients in whom ESWL was considered to be technically successful in only 54 % of patients and in whom technical success was more frequently recorded in patients with solitary stones (19) . CLINICAL 
Early pain relief after endoscopic pancreatic ductal drainage was experienced by 82 %-94 % of patients and can be expected when drainage of the main pancreatic duct is adequate (6, 11, 13). Medium-term clinical improvement was observed in 48 %-84 % of patients in series of more than 50 chronic pancreatitis patients followed during a mean follow-up period of 2 to 5 years after ESWL and endoscopic pancreatic ductal drainage (7, [10] [11] [12] [13] [18] [19] [20] (Table 2) .
Independent predictors of pain relapse at mediumterm follow-up were a high frequency of pain attacks before treatment (5, 11), a long duration of disease before treatment (7, 11), and the presence of a nonpapillary stenosis of the main pancreatic duct (11) . In the series reporting the longest follow-up (14.4 years) a good clinical outcome was recorded in twothirds of the patients and was associated with smoking cessation or absence, but also with a short duration of disease before treatment (17) .
This suggests that ESWL and endoscopic therapy should be initiated as early as possible in the course of chronic pancreatitis because this increases the probability of long-term benefit.
In most series, recurrent pain attacks during the follow-up period were usually related to stone migration or recurrence, progressive stricture of the main pancreatic duct, or pancreatic stent obstruction or dislodgment. In one study, stone recurrence was diagnosed in 35 % of the followed patients at a mean follow-up of 7.4 months after successful treatment, and the calculated "stone free survival time" was 18.5 (13) . Interestingly, the technical and clinical success rates for treatment of recurrent stones were comparable with those of initial therapy.
At long-term follow-up, 16 % to 18 % of the patients were still receiving endotherapy (10, 17) , while 60 % had no further interventional treatment after a mean treatment period of 28.7 months (17) .
Dominant stricture of the main pancreatic duct is often the indication for insertion of a pancreatic stent (9), which is required in about 50 to 60 % of the patients with severe chronic pancreatitis (10, 13, 20) ( Fig. 2C-G) .
Stents can be exchanged on a regular basis (every 2 to 3 months to avoid complications related to stent clogging) (13, 21, 22) or "on demand" (in patients with recurrence of pain and recurrent dilation of the main pancreatic duct) (18, 23) . This strategy means that stent replacement is required after a mean period of 8-12 months (18, 23) .
Two large studies evaluated the long-term outcome of patients after definitive removal of the pancreatic stent (7, 23).
In one study, stents could be removed from 49 patients out of a total of 93 (53 %) after a mean stenting period of 15.7 months, and 73 % of these patients remained pain-free without a stent during a mean follow-up of 3.8 years (7). In the other study, after a median total duration of stenting of 23 months before stent removal, 62 % of the patients maintained satisfactory pain control without pancreatic stent replacement during a median time of 27 months (23). The only significant predictive factor of the need for pancreatic re-stenting within 1 year of stent removal was the presence of pancreas divisum (23) . Interestingly, the majority of patients with pain recurrence which necessitated pancreatic re-stenting, relapsed during the first year after removal of the stent (79 %) and almost all of them (97 %) had relapsed by 24 months. Therefore, if a patient remains stable during the first year after stent removal, subsequent relapse and a consequent need for re-stenting is less likely (23) .
Although pancreatic stent placement may not be the definitive treatment for all patients, it can help to identify whether pancreatic drainage or resection may work best, when surgery finally is performed at a later date.
In connection with this, it has been shown that pancreatic stenting does not prevent or complicate surgery (pancreaticojejunostomy) that may be warranted (24) .
The insertion of multiple stents into the main pancreatic duct is currently under investigation in several centers in order to obtain a greater stricture dilation, a lower frequency of simultaneous stent occlusion, a possible drainage of pancreatic secretions alongside the stents even if all stents occlude, and maybe a longer interval between stent replacements and a higher rate of stricture calibration.
Moreover, in case of main pancreatic duct drainage failure caused by complete obstruction or rupture of the main pancreatic duct, a new technique has been described for draining the dilated main pancre-atic duct through an endoscopically created fistula to the digestive tract under fluoroscopic and echographic guidance (25) . The endoscopically created pancreaticogastrostomy or pancreaticobulbostomy is kept open by a stent inserted into the main pancreatic duct through the large channel of the new echoendoscopes. The advantages of this technique are that it creates a true pancreaticogastric or pancreaticoduodenal fistula that might not be dependent on stent patency.
IMPACT OF PANCREATIC DUCT DRAINAGE ON PANCREATIC ENDOCRINE AND EXOCRINE FUNCTIONS
By contrast with the results of the large multicenter study showing that clinical signs and symptoms correlating with pancreatic function did not improve during the follow-up period (10), we have observed in our long-term study that endoscopic ductal drainage including ESWL can delay the development of clinical steatorrhea for about 10 years compared to the natural history of chronic pancreatitis patients (17, 26) . The risk for appearance of de novo steatorrhea was higher in alcoholic patients and was significantly associated with a long duration of symptomatic ductal obstruction (17) .
However, according to previous studies (10, 19) , including surgical series (27) , the development of diabetes mellitus was not prevented by pancreatic duct drainage but was only related to alcohol abuse in our series (17) .
This suggests that the exocrine pancreatic function is dependent on early relief of ductal obstruction while the endocrine pancreatic function seems mainly dependent on alcohol consumption habits.
DRAINAGE OF PANCREATIC PSEUDOCYSTS
Pancreatic pseudocysts are nonepithelial lined fluid collections that result from transient or persistent pancreatic duct disruption. In the setting of chronic pancreatitis, symptomatic pseudocysts occur in 20 % to 40 % of patients, and less than 10 % will resolve spontaneously (28) .
Approximately 80 % to 95 % of symptomatic pancreatic pseudocysts can be successfully treated using endoscopic transpapillary or transmural drainage (29) . Drainage is indicated to relieve symptoms associated with a space-occupying mass, including adjacent organ compression (gastric outlet obstruction or jaundice from bile duct compression), and to treat complications (spontaneous infection resulting in abscess formation, vascular occlusion, fistula formation,…).
METHODS
Currently, the authors believe that MRI is mandatory for the planning of pseudocyst drainage, particularly to evaluate the size, number and location of the pseudocysts, the proportions of fluid and necrotic debris in the cystic content, the presence of associated ductal lesions (such as coexistent stones and/or Two months after pancreatic duct stenting, he presented recurrent pain due to a pseudocyst located in the uncinate process (see Fig.  1B ), and probably secondary to residual fragment stones in the side branch (see Fig. 2B-F) . A. diathermic needle was used to perform the endoscopic ultrasound-guided transduodenal puncture (A). After injection of contrast medium and insertion of a guide wire (B), the puncture site was enlarged using the cystenterostome (C-D). A straight 10F-5 cm stent, threaded over a guiding catheter (E), was placed in the pseudocyst (F) to maintain the long-term patency of the fistula.
strictures that also have to be addressed), the presence of a connection between the ductal system and the pseudocyst, the presence of associated vascular lesions such as pseudoaneurysm or venous thrombosis, and any compression of adjacent organs (stomach, duodenum, and common bile duct) ( Fig. 1B) . Endoscopic transpapillary stent placement is a treatment option when communication is shown between the pseudocyst and the pancreatic duct and is more suitable for the drainage of small (< 6 cm) and solitary pseudocyst, remote from the gastric and duodenal wall, especially in cases associated with downstream ductal obstruction by stones or strictures (28) (29) (30) (31) . For transpapillary drainage, endoscopic pancreatic sphincterotomy is usually done before advancing the pancreatic stent either into the cyst or the upstream duct in case of pseudocyst associated to a partial rupture of the main pancreatic duct (32, 33) .
Patients are selected for transmural drainage when the pseudocyst is close (< 1 cm) to the gastric or the duodenal wall and is clearly seen to indent the wall at endoscopy (34) .
However, the introduction of larger-channel linear-array echoendoscopes has expanded the indications of transmural drainage to pseudocysts in which there is no bulging of the gastroduodenal wall (35, 36) .
The technique for endoscopic ultrasound -guided transmural pseudocyst decompression has been well described elsewhere (9, [35] [36] [37] . Briefly, the pseudocyst is located and the contact zone between the gastric or duodenal wall and the cyst wall is identified. Doppler is used to assess the puncture area for interposed vessels. Puncture is performed using a 19G needle or a diathermic needle with a pure-cutting current. A sample of the cyst content is aspirated for biochemical, cytologic and bacteriological analysis. Then, the pseudocyst is filled with contrast medium and a guide-wire is inserted deep into the pseudo-cyst cavity. The puncture site is enlarged using either a cystenterostome or a dilating hydrostatic balloon catheter. Finally, one or two 10-F stent(s) are placed with or without a naso-cystic drain (in case of debris or infected material for saline irrigation) ( Fig. 3) . Antibiotic prophylaxis is given in all cases at the start of the procedure to reduce the risk of pseudocyst infection.
When both transmural and transpapillary drainage are technically feasible, we currently favour transmural drainage because transpapillary drainage is dependent on stent patency.
Finally, in patients with complex ductal and pseudocystic pathology, the two major endoscopic routes can be combined, and additional percutaneous drainage (in case of a single location in the periphery of the cyst), or surgical drainage may be required if the pseudocyst is multiloculated, large, or contains abundant necrotic debris, or if the patient develops systemic sepsis.
RESULTS
In a review of published trials in the pre-endoscopic ultrasound era (37) , technically successful pseudocyst drainage was achieved by endoscopic therapy in 81 % to 97 % of cases involving transpapillary drainage alone (for 41 % of the cases), transmural drainage alone (for 43 % of the cases) or combined transpapillary and transmural drainage (for the remaining 16 %). Similar high technical success rates were reported in 2 large series of endoscopic ultrasoundguided transmural drainage of non-bulging pseudocysts (35, 36) (Fig. 4) . Long-term clinical success rate was reported in 75 % of the cases during a mean follow-up period of 9 to 48 months for endoscopic cystenterostomy and 15 to 37 months for transpapillary cyst drainage (28) ( Table 3) . Fig. 4 . Same patient as in Figs 1, 2 and 3 . Six months after pancreatic ductal stenting and cystoduodenostomy, unenhanced (A) and Secretin-enhanced magnetic resonance cholangiopancreatography showed a significant decrease in main pancreatic duct diameter (compare to Fig. 1A) , the disappearance of the pseudocyst (compare to Fig. 1B) , and patency of the pancreatic ductal stent and of the cystoduodenal stent as evidenced by the duodenal filling after secretin stimulation that returned to a normal value (B).
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DRAINAGE OF THE COMMON BILE DUCT
Common bile duct stenosis is a result of pancreatic head inflammatory or fibrotic changes or may be related to compression by a pancreatic pseudocyst. Its prevalence rates range from 3%to 45 % of patients with chronic pancreatitis, but only about 10 % actually develop symptoms related to biliary obstruction (34) .
Endoscopic stenting of distal stenoses of the common bile duct is an effective approach for temporary biliary decompression in chronic pancreatitis patients presenting with cholangitis or persistent obstructive jaundice (38) .
The standard technique for endoscopic biliary drainage includes usually an endoscopic biliary sphincterotomy followed by dilation of the stricture and insertion of a single plastic stent with the largest possible diameter, bridging the stricture (3). All patients are treated prophylactically with antibiotics. Tissue samples are obtained with brush and/or forceps to confirm the benign nature of the stricture in all patients. Stents are regularly exchanged either at scheduled intervals of 3-4 months during an average stenting period of 12 months or when recurrent Devière (45) Self-expanding metal stent2 0 0 -9 03 3 van Berkel (46) Self-expanding metal stent 13 0 -3 85 0 m: months ND: not determined symptoms of bile duct obstruction occur secondary to stent clogging or migration (39) (40) (41) (42) (43) (44) .
Although technical success and immediate clinical success were nearly 100 % in all studies, satisfactory long-term success was achieved in only one (41) , in which good long-term results were obtained in 80 % of patients at a mean follow-up of 32 months after stent removal. In the remaining studies, stricture resolution was observed in the long-term in 12 % to 38 % of patients (39) (40) (41) (42) (43) (44) (Table 4 ).
The success noted by Vitale et al (41) may be attributable to several factors, namely a less severe chronic pancreatitis in the patients of this series with only 16 % of patients with pancreatic calcifications. Indeed, the only predictive risk factor for failure of endoscopic plastic biliary stenting identified in chronic pancreatitis patients was the presence of calcifications in the pancreatic head (8 % of long-term success in 39 patients with calcifications of the pancreatic head vs 59 % in 22 patients without calcifications; p < 0.001) (43) .
These long-term disappointing results could be improved by sequential endoscopic insertion of multiple plastic biliary stents as recently reported (38) . With this policy, single stent was added sequential- (Table 4) . Finally, for patients non-responding to plastic stent(s) insertion and who are unfit for surgery, the use of self-expanding metal stents may be a valuable treatment option giving acceptable long-term success rates between 38 % and 90 % (45, 46) . The main problem is the development of epithelial hyperplasia leading to stent obstruction but the calculated mean patency period was 60 months in one study (46) .
Future investigation might focus on the use of selfexpandable plastic stent, covered metal stent, or biodegradable stent, but at present no data are available on the use of these materials for patients with bile duct stricture associated with chronic pancreatitis.
COMPLICATIONS AND LATE OUTCOME
The early complication rates of endoscopic treatment for chronic pancreatitis patients seem to be lower in chronic pancreatitis than in other indications, perhaps because of the higher experience of endoscopists who start their training at the biliary system or because of the periductal fibrosis and limited amounts of nearby acinar tissue associated with chronic pancreatitis (4).
Early complications occur in 4.2 % to 16 % of cases and include exacerbation of mild pancreatitis (2.9 %-9 %), bleeding (0 %-3.6 %), cholangitis (3.6 %-4.3 %), and, in rare instances, perforation (9). Pancreatic duct drainage (by nasopancreatic catheter or stent) has been proposed to prevent complications (mainly acute pancreatitis) after endoscopic pancreatic sphincterotomy, but no evidence for a benefit has been provided in chronic pancreatitis patients, as the risk in this group of patients is particularly low (4).
After ESWL, mild side effects have been noted, such as petechiae on the skin at the area of shockwave penetration. Erosions in the gastric antrum, sometimes hemorrhagic, and duodenal edema have also been observed, when endoscopy was performed just after ESWL, but none of these side effects had overt clinical consequences (6).
Early complications of pseudocyst drainage procedures occur in about 10 % of patients (28, 29) . Endoscopic cystenterostomy is associated with a higher complication rate than transpapillary drainage. The major complications reported are bleeding, infection and retroperitoneal leakage. Bleeding results from the rupture of an undetected pseudoaneurysm or of a gastric wall vessel. Coil embolization by angiography of the bleeding vessel or endoscopic coagulation at the puncture site usually succeeds in controlling this complication (29) .
Late complications are related to pancreatic or biliary stent clogging or dislocation causing recurrent pain, bouts of pancreatitis, and possibly infection and cholangitis (13, 23, 38, 43) .
In the author's experience, these complications were successfully treated with conservative measures, and no procedure-related mortality was recorded.
In most series with a long-term follow-up, surgery became necessary for about 20 % of chronic pancreatitis patients initially treated by endotherapy (10, 17) , either for early technical failure (intractable pain after unsuccessful endoscopic treatment), or later, for definitive biliary drainage or for pancreatic ductal drainage when repetitive endoscopic treatment is considered too frequent in these young patients (17) . In case of clinical failure despite technical success, further attempts at surgical drainage usually are useless and resection would be more beneficial than decompression.
In our long-term studies (17), late mortality occurred in 42 % of patients after a mean lifetime of 12 years from the clinical onset of chronic pancreatitis. Most common causes of death were malignancies and complications of pancreatitis (mainly diabetes). Alcohol consumption was identified as the only risk factor for mortality in this study (survival of 49 % and 95 % at the end of the follow-up time of 14.4 years, respectively for alcohol-induced chronic pancreatitis and non-alcohol-induced chronic pancreatitis; p = 0.0012) (17) .
DISCUSSION
Over the past 25 years, interventional endoscopy has been used increasingly as a less-invasive alternative to conventional surgery for the treatment of painful obstructive chronic pancreatitis and of its complications such as pseudocysts and bile duct stricture.
A mounting body of evidence suggests that endoscopic therapy for pancreatic ductal disease in patients with symptomatic chronic pancreatitis is effective, technically feasible in the majority of patients and has an acceptable complication rate.
Contrary to surgery, endoscopic therapy can be performed repeatedly in response to recurrences of pain, and has a high clinical success rate that is similar to that for initial therapy (13) . Moreover, patient age is not significant as a risk factor for procedurerelated morbidity and mortality, and finally endotherapy does not preclude subsequent surgery, should this become necessary (24) .
However, data remain difficult to interpret due to uncontrolled and retrospective study designs, involvement of heterogeneous patient populations, and use of varying simultaneous endoscopic techniques.
A randomized controlled trial would be of considerable interest comparing endotherapy with pancreatic surgical drainage in selected patients with dilated main pancreatic duct due to obstruction by stone(s) and/or stricture(s). Unfortunately, it was our personal experience that patients who were specifically referred for endoscopic therapy, mostly after failure of conservative treatment, in many cases refused randomization for inclusion in studies comparing two treatments that had such different levels of invasiveness.
There is only one published randomized controlled trial in which endotherapy was compared with surgery (20) . In this trial, similar efficacy was reported with both procedures for short-term pain control in obstructive chronic pancreatitis, but surgery was better for mid-term pain control. However, in this study, surgery included resection for 80 % of patients, which is difficult to compare with endoscopic ductal drainage; repetitive endoscopic therapy (in case of symptom recurrence) and ESWL were lacking which may have contributed to the reduced success rate for patients randomized in the endoscopic treatment group.
Indeed, we have shown that repeat endotherapy is very often needed in the early period post-initial treatment (17) and that ESWL is needed in about 40 % of cases (6).
In the absence of randomized controlled trial, case series with careful patient selection, strict definition of successful outcome and long-term follow-up would provide the most accurate information to assess interventional methods (47) .
As an example, Baron et al retrospectively studied differences in the outcome after endoscopic drainage of various well-defined types of symptomatic pancreatic fluid collections (48) . The multivariate analysis showed that chronic pseudocysts were predictive of successful drainage as compared to organized pancreatic necrosis. This large retrospective analysis confirms previous results indicating that endotherapy is an effective and safe treatment for chronic pancreatitis patients with symptomatic pseudocysts.
Common bile duct stricture caused by chronic pancretitis has proven to be a significant clinical problem, especially in patients affected by a calcified form of chronic pancreatitis, with major drawbacks being the need for multiple procedures and late morbidity secondary to stent clogging and migration. Sequential placement of multiple, large diameter stents in patients with common bile duct stenosis related to chronic pancreatitis, might improve the compliance of the fibrotic pancreatic parenchyma surrounding the distal bile duct, and hence lead to a better sustained clinical outcome (38) .
Finally, proper patient selection based on adequate non invasive imaging procedures, increasing expertise, and a supporting multidisciplinary infrastructure are essential to offer the best palliative treatment to these patients suffering from chronic pancreatitis.
Hopefully, technological developments in therapeutic endoscopy will proceed in the next years to further extend the scope of therapeutic pancreatic endoscopy.
